Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company’s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals. 

Biotechnology

Health Care

Life Sciences

Therapeutics

Radionetics Oncology

Radionetics Oncology's headquarters in San Diego, United States

Paul Grayson

Alyssa Levin

Brett Ewald

Yunfei Zhu

Istvan Molnar

Description

People (18)

Paul Grayson

Istvan Molnar

Yunfei Zhu

Ana Karin Kusnetzow

Julie Selkirk

Greg Reinhart

Dalei Shao

Jillian Basinger Thompson

Brett Ewald

Umesh Gangadharmath

Yifeng Xiong

Kristrun Thordis Stardal

Jonathan Ableson

Lianna Scott

Patrick Fagan

Jean-Michel V.

Yael Cohen-Arazi

Peter Chua

Jobs